Evidence map›Paper›PMID 28334922›Full record

ArticleHuman molecular genetics2017

Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP).

Vikas Mishra, Bharat K Karumuri, Nicole M Gautier, Rui Liu, Timothy N Hutson, Stephanie L Vanhoof-Villalba, Ioannis Vlachos, Leonidas Iasemidis, Edward Glasscock

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. DecipheringArXiv · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Strain-dependent effects on neurobehavioral and seizure phenotypes inbioRxiv : the preprint server for biology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Clinical Spectrum ofInternational journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Vikas MishraDepartment of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Bharat K KarumuriBiomedical Engineering, Louisiana Tech University, Ruston, LA 71272, USA.
Nicole M GautierDepartment of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Rui LiuDepartment of Mathematics and Statistics, Louisiana Tech University, Ruston, LA 71272, USA.
Timothy N HutsonBiomedical Engineering, Louisiana Tech University, Ruston, LA 71272, USA.
Stephanie L Vanhoof-VillalbaDepartment of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Ioannis VlachosDepartment of Mathematics and Statistics, Louisiana Tech University, Ruston, LA 71272, USA.
Leonidas IasemidisBiomedical Engineering, Louisiana Tech University, Ruston, LA 71272, USA.
Edward GlasscockDepartment of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Louisiana Tech University · USLouisiana State University Health Sciences Center Shreveport · US

Funding

Excitability mechanisms of neurocardiac regulationR00HL107641 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GLASSCOCK, ALBERT E · 2013 to 2015
$726k
Complex genetic interactions in mouse model of sudden death in epilepsy (SUDEP)R21NS089397 · NINDS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GLASSCOCK, ALBERT E · 2014 to 2015
$399k
NHLBI NIH HHS R00 HL107641NINDS NIH HHS R21 NS089397
6 · The paper itself

Abstract

People with epilepsy have greatly increased probability of premature mortality due to sudden unexpected death in epilepsy (SUDEP). Identifying which patients are most at risk of SUDEP is hindered by a complex genetic etiology, incomplete understanding of the underlying pathophysiology and lack of prognostic biomarkers. Here we evaluated heterozygous Scn2a gene deletion (Scn2a+/-) as a protective genetic modifier in the Kcna1 knockout mouse (Kcna1-/-) model of SUDEP, while searching for biomarkers of SUDEP risk embedded in electroencephalography (EEG) and electrocardiography (ECG) recordings. The human epilepsy gene Kcna1 encodes voltage-gated Kv1.1 potassium channels that act to dampen neuronal excitability whereas Scn2a encodes voltage-gated Nav1.2 sodium channels important for action potential initiation and conduction. SUDEP-prone Kcna1-/- mice with partial genetic ablation of Nav1.2 channels (i.e. Scn2a+/-; Kcna1-/-) exhibited a two-fold increase in survival. Classical analysis of EEG and ECG recordings separately showed significantly decreased seizure durations in Scn2a+/-; Kcna1-/- mice compared with Kcna1-/- mice, without substantial modification of cardiac abnormalities. Novel analysis of the EEG and ECG together revealed a significant reduction in EEG-ECG association in Kcna1-/- mice compared with wild types, which was partially restored in Scn2a+/-; Kcna1-/- mice. The degree of EEG-ECG association was also proportional to the survival rate of mice across genotypes. These results show that Scn2a gene deletion acts as protective genetic modifier of SUDEP and suggest measures of brain-heart association as potential indices of SUDEP susceptibility.

Indexed as

AnimalsBiomarkersBrainDeath, SuddenDisease Models, AnimalElectrocardiographyElectroencephalographyEpilepsyGenotypeHeartHeart RateKv1.1 Potassium ChannelMiceMice, KnockoutNAV1.2 Voltage-Gated Sodium ChannelSeizuresBiomarkersKcna1 protein, mouseKv1.1 Potassium ChannelNAV1.2 Voltage-Gated Sodium ChannelScn2a protein, mouse

Identifiers

PMID28334922
PMCPMC6075631
OpenAlexW2596143930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.